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Abstract
This paper provides details on the necessary steps to assess and control data
in genome wide association studies (GWAS) using genotype information on a
large number of genetic markers for large number of individuals. Due to varied
study designs and genotyping platforms between multiple sites/projects as well
as potential genotyping errors, it is important to ensure high quality data.
Scripts and directions are provided to facilitate others in this process.
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Introduction
Biases and errors can lead to erroneous associations in casecontrol association tests. Quality control (QC) that removes markers and individuals from a study that may introduce these biases
can greatly increase the accuracy of findings. There are many
examples of best practices for GWAS QC1,2. This paper describes
some standard QC steps and also provides links to automated
scripts to perform QC making the process easier and easily reproducible. Standard tools such as PLINK3 and SMARTPCA4,5 are
called by the scripts.
Due to the need for reproducibility in science, automated pipelines
that can be used to repeat computational experiments and save relevant parameters is extremely important. Done step-by-step, the
QC process can be quite lengthy (about 8 hours for an expert and
almost certainly longer for a novice and/or someone with limited
computational resources according to Anderson et al.1) and difficult
to repeat exactly. Here we present scripts that perform automated
GWAS QC using a parameter file that can be saved to redo the
process and save human time. A log file is produced that summarizes the process to easily compare different QC parameters and
their effects on the data.

Methods
Implementation
QC steps implemented in this pipeline. The steps automated here
mostly follow the notes on QC6 developed by MikeWeale and
also calls some R7 scripts described in his notes during the QC

pipeline. It is assumed that input files are already in PLINK format.
Figure 1 shows a complete QC pipeline that includes combining
data from multiple chromosomes and studies and two portions
of the QC pipeline. There are two scripts, QC.py which takes
advantage of PLINK calls and also PCA.py that does principal
component analysis to investigate population stratification.
1. Gender mismatches
    The optional first step in the automated pipeline is a check
for gender mismatch using the PLINK ‘-- check-sex’ command. This command compares the sex reported in the .fam
file and the sex imputed from the X chromosome inbreeding coefficients. This step automatically removes individuals
where problems are identified. The step was made
optional because our dataset of interest is matched with
phenotype/clinical data of higher accuracy. This step can be
turned off using the parameter file as described below in the
Operation section.
2. Thresholds
    The next steps in this pipeline include checking and applying thresholds for minor allele frequency (MAF), missingness for each individual, and missingness of markers. Minor
allele frequency filtering is important because rare genotypes
will not show up as often and thus will have less evidence
in a GWAS and the calls will be less certain and it is also
difficult to detect associations with them. Missingness can
lead to false associations if it is non-random with respect to
phenotypes or genotypes. Single nucleotide polymorphism

Figure 1. Full QC Pipeline.
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(SNP) missingness is the complement to individual missingness and is correlated with SNP quality from the original
genotyping assay. Missingness is investigated using PLINK
‘--missing’ and plots are generated as described by Weale6.
All the plots that are generated during the process are compressed at the end in order to facilitate downloading them
when the process is performed remotely on a cluster.
    In order to attempt to retain the largest number of markers and individuals that pass QC there is an option to do a
two-tiered missingness by individuals filtering. We noticed
during testing that this could sometimes lead to final datasets with higher numbers of both. If a value is supplied to
the #MIND1 parameter (described below in Operations),
then this (expectedly non-stringent) threshold for PLINK
‘--mind’ is used first and the more stringent #MIND is
applied in the same step as the PLINK ‘--geno’ and ‘--maf’
thresholds for missingness of markers and minor allele
frequency, respectively. If a major reduction in the number
of markers or individuals is found during these steps,
investigation of the generated graphs can help adjust these
thresholds. See notes6 for more information.
    Some reasoning8 suggests that a minor allele frequency
threshold should be set to 10/n where n is the number of
markers. The #MAF parameter can be set to ‘na’ which will
use 10/n as a threshold or a threshold value can be explicitly
given, such as ‘.01’.
3. Heterozygosity
    Individuals resulting from random mating within a population should have predictable heterozygosity (H) values.
H is a measure of the number of loci in an individual that
are heterozygous. Departure from expected H values can
signify DNA quality issues (high H) or samples from a different population (low H). This step can be turned off by
not supplying the ‘#HET’ parameter in the parameter file.
As long as the parameter is listed, this step will be done.
H and the inversely related F (Method-of moments F coefficient estimate) are investigated using PLINK ‘--het’. F is
calculated as the ([observed homozygous count] - [expected
count])/([total observations] - [expected count])) where the
expected count is calculated from an imputed MAF. A histogram of F values is generated for manual investigation.
    If values for ‘#FMIN’ and ‘#FMAX’ are supplied in the
parameter file then samples with an F value below ‘#FMIN’
and above ‘#FMAX’ are removed. If these values are not supplied then samples above or below three standard deviations
of the mean H are removed, as suggested be Anderson et al.1.
4. Hardy-Weinberg equilibrium (HWE)
    Markers out of HWE can indicate that there were genotyping
errors. However, a strong association signal can also result
in deviations from HWE. So here only variants from control samples are checked for deviations from HWE. PLINK
‘--hardy’ is used to generate HWE p-values and a Q-Q
plot of the log-P-values of the markers for the controls is
generated for manual investigation. A p-value threshold is

supplied in the parameter file to remove markers with a pvalue lower than expected.
5. Cryptic relatedness
    Cryptic relatedness (CR) is when pairs of individuals are
closely related and can lead to false positive or negative
correlations when subjects are treated as independent. The
PLINK ‘--genome’ command can estimate relatedness, but
is quite slow when there are a large number of markers in a
dataset. Therefore, markers in high linkage disequilibrium
(LD) are removed first to thin the data. This is done using
PLINK ‘--indep-pairwise’ with parameters suggested by
Weale6. This creates a pruned data set that contains markers with a minimal LD (which is caused by limited recombination occurring between two or more loci and results in
a non-random association between the loci). Furthermore,
only assayed markers are used in this step (i.e. not imputed
markers). Using a pruned data set is advantages because CR
methods work best when no LD is assumed between markers
and it also reduces the input size and in turn greatly reduces
the computation time.
    PLINK ‘--genome’ estimates relatedness of all pairs of
samples and reports identify by decent (IBD, a measure of
whether identical regions of two genomes were inherited
from the same ancestry) in the PI_HAT (actually, proportional IBD, i.e. P(IBD=2) + 0.5*P(IBD=1)) column of the
result file. A PI_HAT value close to 1 would indicate a duplicate sample. The threshold 0.1875 represents the half-way
point between 2nd and 3rd degree relatives and is a common
cut-off to use. Of each pair of related individuals, the one
with the greater proportion of missing SNPs is dropped from
the final dataset.
6. Principal component analysis (PCA)
    Generally, PCA transforms a data matrix (such as a GWAS
n x m matrix where n in is the number of individuals and
m is the number of markers and each element in the matrix
represents the scaled genotype for the particular individual
at that particular marker) so that the successive principal
components are not correlated. The number of PCs is less
than or at most equal to the original number of columns
and the first PC explains the largest variance in the genotype data. Traditionally, PCA is used to (1) screen the study
population for heterogeneous ethnic backgrounds and (2) to
correct for potential population stratification (the difference
of allele frequencies in ancestral subpopulations). It can be
seen in Figure 2 where HapMap9,10 data with individuals
with known ancestry are included in the PCA, when plotting
the first two PCs subpopulations cluster together. HapMap is
an international project that aims to identify genetic similarities and differences between populations.
    As with the cryptic relatedness step, a thinned dataset
created with PLINK and starting from assayed markers only
is used to calculate PCs. The SMARTPCA tool is used to
calculate PCs from this thinned dataset and identify outliers
for removal. The PCs can then be used for further corrections
in analysis models.
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Figure 2. PCA with HapMap data included.

Data Formats. The input GWAS data are expected to be in PLINK
bfile format. The input data will have three files associated to it with
.bed, .bim, and .fam file extensions. The .bed file is a binary file that
contains the genotype information for all individuals (https://www.
cog-genomics.org/plink2/formats#bed). The .bim file is a mapping
file giving information on each marker (https://www.cog-genomics.
org/plink2/formats#bim). The .fam file gives information on each
individual (https://www.cog-genomics.org/plink2/formats#fam).
This pipeline utilizes information that was not provided in the
original PLINK files and therefore the phenotype is always provided in an alternate phenotype file. PLINK ‘–pheno’ is used to
provide the phenotype file and PLINK ‘–pheno-name’ is used to
provide the phenotype name which also corresponds to the header
of the column in the phenotype file. The first two columns in the
phenotype file must have the column headers ‘FID’ and ‘IID’
respectively. ‘FID’ is the family ID or ‘0’ if not used and ‘IID’ is the
individual ID that corresponds to the ‘IID’ values in the .fam file
(https://www.cog-genomics.org/plink2/input#pheno).

Parameter files. Example parameter files are shown in Figure 3.
The QC.py and PCA.py scripts read in parameters and names them
based on the word following the ‘#’ and gives that parameter the
value following the white space on the same line. The line numbers in the figure are not a part of the parameter file (i.e. each line
starts with ‘#’). The parameters and values are stored in a python
dictionary, so order and extra parameters do not matter. However,
the exact name and case of the parameters are important for the
scripts to correctly function. The parameters described here are
ordered by the line number given in the qc_params.txt file in
Figure 3a. The parameters with the same name in the pca_params.
txt file in Figure 3b have the same meaning.
  1. WORK – path to the working directory where all generated
files will be written
  2. RPATH – path to where Rscript is located, or name if in a
known path
  3. PLINKPATH – path to the PLINK executable, or name if
in a known path

Operation
System. The pipeline was tested on STATGEN, a Dell PowerEdge
R520 server with two Intel Xeon E5-2470 CPUs (32 cores at
2.3GHz), 24TB of storage in a RAID6 array with two drive fault
tolerance, and 128GB of RAM. The operating system is Ubuntu
Server 14.04 LTS 64-bit edition.

  4. INPUT – input file in PLINK bfile format

Required software. The automated pipeline is written in Python
and calls Rscript, PLINK, and SMARTPCA. The versions used for
building and testing are the following,

  8. GENO – marker missingness threshold

  5. SCRIPTS – path to directory in which the helper scripts
called by the pipeline live
  6. MAF – minor allele frequency threshold
  7. MIND – individual missingness threshold
  9. HWE – Hardy-Weinberg threshold

1. Python - Python 2.7.6

10. PI_HAT – IDB threshold

2. Rscript - R scripting front-end version 3.2.2
3. PLINK - PLINK v1.90b3x 64-bit

11. SEX – if value is equal to ‘yes’ then a PLINK sex check is
performed, otherwise it is not

4. SMARTPCA – smartpca version 13050

12. ASSAYED – location of file that includes names of all
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Figure 3. Parameter files a) qc_params.txt b) pca_params.txt.

assayed markers in a study to ensure that imputed SNPs
are not used for some QC steps
13. MIND1 – an optional, first tier (non-stringent) individual
missingness threshold
14. HET – if this parameter is included then the Heterozygosity
step is performed (NOTE since ‘#FMIN’ and ‘#FMAX’
are not given, this parameter file will result in the removal
of markers with an H value +/- 3 standard deviations)
15. CLEAN – will result in the removal of intermediate files
and final PLINK finals to be named ‘final’
16. PHENO – the name of the phenotype that will be investigated during analysis. Some QC steps vary based on
whether or not an individual is case, control, or undefined.
17. PFILE – the files in which the phenotype is given formatted
in the proper PLINK format with FID, IID, pheno1 column
headers where FID is the family ID (commonly 0 if relations not known), the individual’s ID, and the phenotype
value encoded as 1=unaffected (control) and 2=affected
(case).
18. SMARTPCA (line #2 in pca_params.txt and not in
qc_params.txt) – link to the smartpca executable.
Running scripts and results
1. QC.py
    Once the parameters and values are correctly written to
the parameter file, the script is executed by calling the
parameter file as a command line argument as follows,
                                   python QC.py qc_params.txt
    The QC steps are performed as described in the Implementation section and after each step a count is retrieved for the
number of individuals or markers removed in each step. A
log file is written (final_QC.log). All of the parameters from

qc_params.txt are first written to the log file to ensure the
process can be duplicated. Then the number of individuals/
markers removed during each step are recorded along with
the running total of how many individuals and markers are
left in the dataset. This allows for easy comparison of the
overall effects of different parameter settings. If ‘#CLEAN’
is set then the final QC dataset is in PLINK format and
named ‘final.bed’, ‘final.bim’, and ‘final.fam’. There will
be an archived file ‘final_graphs.tgz’ containing the files
missing.png, het.png, hwe.png, and relate.png, created in
the thresholds, hetereozygosity, and HWE steps above for
manual inspection in case parameters need to be adjusted
and QC redone.
2. PCA.py
    Once the parameters and values are correctly written to
the parameter file, the scripts is executed by calling the
parameter file as a command line argument as follows,
                       python PCA.py pca_params.txt
    The data thinning is carried out in PLINK, the input file for
SMARTPCA is automatically generated, and then SMARTPCA is called to calculate the PCs. If the analysis is being
done in R, then the ‘smartpca.evec’ file can be read in and
merged to exclude individuals in which PCs were not calculated (i.e. outliers). PCA.py also generates a file called
‘remove.txt’ in PLINK format with an FID (all marked ‘0’)
and IID column so that the outliers can be removed during
PLINK analysis with the ‘–remove’ command.

Conclusions
While the QC steps given here are not novel, this paper provides
access to an automated process that both reduces human work time
and chances for error and provides tools to make the computational
experiment reproducible. It also gives recommended values for
parameters but facilitates changing parameters and the comparison
of effects.
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Software availability
Zenodo: GWAS: Automated GWAS QC, doi: 10.5281/zenodo.5822811.
GitHub: https://github.com/sallyrose0425/GWAS, https://github.
com/sallyrose0425/GWAS/blob/master/LICENSE
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quality control measures for genomewide association studies The scripts address critical questions for
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whether it is as expected, checking whether there are markers that do not follow Hardy-Weinberg
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